KUOPIO UNIVERSITY HOSPITAL
Desconocido
SLEEP REVOLUTION: Revolution of sleep diagnostics and personalized health care based on digital diagnostics and therap...
POHJOISSAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
participó en un
H2020:
H2020-SC1-BHC-2018-2020
Obstructive sleep apnea (OSA) is associated with various negative health consequences including increased risk of heart disease, hypertensio...
2021-02-01 - 2025-02-28 | Financiado
2021-02-01 - 2025-02-28 | Financiado
euCanSHare: An EU Canada joint infrastructure for next generation multi Study Heart research
POHJOISSAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
participó en un
H2020:
H2020-SC1-BHC-2018-2020
EuCanSHare will develop the first centralised, secure and sustainable platform for enhanced cross-border data sharing and multi-cohort perso...
2018-11-21 - 2023-05-31 | Financiado
2018-11-21 - 2023-05-31 | Financiado
CardioReGenix: CardioReGenix Development of Next Generation Gene Therapies for Cardiovascular Disease
POHJOISSAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
participó en un
H2020:
H2020-SC1-BHC-2018-2020
WHO estimates 17.7 million people die each year from cardiovascular disease (CVD), an estimated 31% of all deaths worldwide. While progress...
2018-11-21 - 2024-06-30 | Financiado
2018-11-21 - 2024-06-30 | Financiado
MIRACLE: Mid infrared arthroscopy innovative imaging system for real time clinical in depth examination and d...
POHJOISSAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
participó en un
H2020:
H2020-ICT-2016-2017
MIRACLE will take towards commercialization the first mid-infrared (MIR) arthroscopy probe for in-depth evaluation of articular cartilage en...
2017-12-19 - 2022-03-31 | Financiado
2017-12-19 - 2022-03-31 | Financiado
ReGenHeart: Clinical development and proof of principle testing of new regenerative VEGF D therapy for cost effe...
POHJOISSAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
tramitó un
H2020:
H2020-SC1-2016-2017
Chronic angina pectoris is a debilitating chronic disease, a subgroup of these patients suffers from refractory angina which unfortunately c...
2016-12-01 - 2022-12-31 | Financiado
2016-12-01 - 2022-12-31 | Financiado
ChiLTERN: Children s Liver Tumour European Research Network
POHJOISSAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
participó en un
H2020:
H2020-PHC-2014-2015
Liver cancer in the paediatric population is rare with an incidence approximately 1-1.5 per million population. The commonest tumour seen in...
2015-12-07 - 2021-12-31 | Financiado
2015-12-07 - 2021-12-31 | Financiado
WOMEN-UP: Cost effective self management of urinary incontinence addressed to women across Europe
POHJOISSAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
participó en un
H2020:
H2020-PHC-2014-2015
Urinary incontinence (UI), considered as a disease according to the World Health Organization (WHO), is not a life-threatening condition, bu...
2014-12-11 - 2019-05-31 | Financiado
2014-12-11 - 2019-05-31 | Financiado
INEXCA: Excellent research and expertise of quality of cancer care by internationally trained staff
POHJOISSAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
participó en un
H2020:
H2020-MSCA-RISE-2014
There is an international imperative to improve healthcare through health service research, including nursing research and new innovations....
2014-11-25 - 2019-02-28 | Financiado
2014-11-25 - 2019-02-28 | Financiado
COSMOPHOS-NANO: Novel nanotechnology enabled system for endovascular in vivo near infrared fluorescence molecular im...
POHJOISSAVON SAIRAANHOITOPIIRIN KUNTAYHTYMA
participó en un
FP7:
CosmoPHOS-nano is a multidisciplinary, translational and business-oriented project, aiming to accomplish the following objectives:
1) develo...
Financiado
Financiado
* No se disponen de datos de la empresa actual.